FCGR2A and viral infectious disease: Besides, some anti-RBD neutralizing antibodies also showed FcγR-mediated enhancement of virus infection in vitro, but not in vivo [34,35] As AdC7-RBD-tr2 express dimeric RBD protein, without induction of anti-NTD antibodies, which suggests its advantage of reducing the potential ADE risk.